Roger Paredes, MD, PhD
Roger Paredes, MD, PhD
Infectious Diseases Service & irsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias
Verified email at irsicaixa.es
TitleCited byYear
2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ...
Topics in antiviral medicine 19 (4), 156, 2011
11592011
2015 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ...
Top Antivir Med 23 (4), 132-41, 2015
5842015
Special contribution 2014 Update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 22 (3), 642, 2014
584*2014
Special contribution 2014 Update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 22 (3), 642, 2014
584*2014
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
MJ Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ...
Nature medicine 16 (4), 460, 2010
5472010
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ...
The Lancet infectious diseases 11 (5), 363-371, 2011
3552011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
JZ Li, R Paredes, HJ Ribaudo, ES Svarovskaia, KJ Metzner, MJ Kozal, ...
Jama 305 (13), 1327-1335, 2011
3262011
Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
A Tuldrà, CR Fumaz, MJ Ferrer, R Bayés, A Arnó, M Balagué, A Bonjoch, ...
Journal of acquired immune deficiency syndromes (1999) 25 (3), 221-228, 2000
3092000
Update of the drug resistance mutations in HIV-1: March 2013
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, RW Shafer, ...
Topics in antiviral medicine 21 (1), 6, 2013
2962013
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
AJ Rodger, R Lodwick, M Schechter, S Deeks, J Amin, R Gilson, ...
Aids 27 (6), 973-979, 2013
2882013
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study
R Paredes, A Mocroft, O Kirk, A Lazzarin, SE Barton, J Van Lunzen, ...
Archives of internal medicine 160 (8), 1123-1132, 2000
2822000
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
L Ruiz, J Martinez-Picado, J Romeu, R Paredes, MK Zayat, S Marfil, ...
Aids 14 (4), 397-403, 2000
2302000
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo
AMN Tsibris, B Korber, R Arnaout, C Russ, CC Lo, T Leitner, B Gaschen, ...
PloS one 4 (5), 2009
2262009
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and …
E Negredo, L Cruz, R Paredes, L Ruiz, CR Fumaz, A Bonjoch, S Gel, ...
Clinical infectious diseases 34 (4), 504-510, 2002
2082002
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure
R Paredes, CM Lalama, HJ Ribaudo, BR Schackman, C Shikuma, ...
The Journal of infectious diseases 201 (5), 662-671, 2010
2062010
Barriers to reducing urinary catheter use: a qualitative assessment of a statewide initiative
SL Krein, CP Kowalski, M Harrod, J Forman, S Saint
JAMA internal medicine 173 (10), 881-886, 2013
202*2013
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy: 1-year prospective follow-up of a …
L Ruiz, E Negredo, P Domingo, R Paredes, E Francia, M Balagué, S Gel, ...
Journal of acquired immune deficiency syndromes (1999) 27 (3), 229-236, 2001
2022001
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
L Ruiz, G Carcelain, J Martínez-Picado, S Frost, S Marfil, R Paredes, ...
Aids 15 (9), F19-F27, 2001
1772001
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens
CR Fumaz, A Tuldra, MJ Ferrer, R Paredes, A Bonjoch, T Jou, E Negredo, ...
JAIDS-HAGERSTOWN MD- 29 (3), 244-253, 2002
1752002
Gut microbiota linked to sexual preference and HIV infection
M Noguera-Julian, M Rocafort, Y Guillén, J Rivera, M Casadellà, P Nowak, ...
EBioMedicine 5, 135-146, 2016
1602016
The system can't perform the operation now. Try again later.
Articles 1–20